Publication | Closed Access
Efficacy of Eletriptan in Migraineurs With Persistent Poor Response to Nonsteroidal Anti‐inflammatory Drugs
20
Citations
29
References
2003
Year
Results of this open-label trial found the 40-mg dose of eletriptan to have a high degree of efficacy and tolerability among patients who responded poorly to nonsteroidal anti-inflammatory drugs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1